GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Il Yang Pharmaceutical Co Ltd (XKRX:007570) » Definitions » ROCE %

Il Yang Pharmaceutical Co (XKRX:007570) ROCE % : 7.40% (As of Sep. 2024)


View and export this data going back to 1974. Start your Free Trial

What is Il Yang Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Il Yang Pharmaceutical Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 7.40%.


Il Yang Pharmaceutical Co ROCE % Historical Data

The historical data trend for Il Yang Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Il Yang Pharmaceutical Co ROCE % Chart

Il Yang Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.61 12.10 14.69 14.42 2.26

Il Yang Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.00 -9.48 5.51 3.71 7.40

Il Yang Pharmaceutical Co ROCE % Calculation

Il Yang Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=6739.471/( ( (498185.237 - 186859.386) + (459455.967 - 173674.352) )/ 2 )
=6739.471/( (311325.851+285781.615)/ 2 )
=6739.471/298553.733
=2.26 %

Il Yang Pharmaceutical Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=22000.872/( ( (496665.101 - 205039.894) + (533614.768 - 230477.889) )/ 2 )
=22000.872/( ( 291625.207 + 303136.879 )/ 2 )
=22000.872/297381.043
=7.40 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Il Yang Pharmaceutical Co  (XKRX:007570) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Il Yang Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Il Yang Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Il Yang Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
110, hagal-ro, Giheung-gu, Yongin-si, Seoul, Gyeonggi, KOR
Il Yang Pharmaceutical Co Ltd operates in the Korean healthcare sector. The company is mainly a pharmaceutical product manufacturer. Its business is comprised of four product divisions, which are Medicines, Food, Cosmetics, and Antacid raw materials. Its medicines include anticancer and antibiotics and drugs for the liver, digestive system, and anti-inflammatory drugs. Its Foods division is engaged in the manufacture and sale of food supplements and health drinks.

Il Yang Pharmaceutical Co Headlines

No Headlines